Nuedexta Developed
- Center for Neurologic Study
- Nov 10, 2020
- 1 min read
Nuedexta®, a drug discovered at CNS and developed by Avanir Pharmaceuticals, Inc., was approved for sale in the European market in June. For more information about this exciting news, visit here.
Comments